MSK 2020 Psychopharmacology in Cancer Care: An Update for Clinicians of All Disciplines
MSK 2020 Psychopharmacology in Cancer Care: An Update for Clinicians of All Disciplines is organized by Memorial Sloan Kettering Cancer Center (MSKCC) and will be held on Mar 21, 2020 at Rockefeller Research Laboratories - MSKCC, New York City, New York, United States of America.
The target audience for this course is Psychiatrists, Psycho-oncologists, Oncologists, Palliative Care Physicians, Physician Assistants, Nurse Practitioners, Nurses, Psychologists, Social Workers and Counselors.
AMA Credit Designation Statement:
Memorial Sloan Kettering Cancer Center designates this live activity for a maximum activity of 6.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Social Work Accreditation Statement:
This presentation is approved for a maximum of 6.50 Continuing Education Contact Hours of Live In-Person/Live Online Training. Memorial Sloan-Kettering Cancer Center is recognized by the New York State Education Department's State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0228.
ANCC CNE Statement:
6.75 NCPD contact hours will be awarded to participants who attend a live program, in its entirety, and complete a program evaluation. Partial credit not awarded.
Clinicians have numerous tools at their disposal to help adult cancer patients dealing with symptoms of depression, anxiety, and other cancer sequelae. Psychiatric medications are most frequently prescribed to cancer patients by oncologists and general practitioners, however psychiatric syndromes are often underdiagnosed and undertreated. Few oncology practices have dedicated psychiatric consultants familiar with the nuances of Psycho-Oncology. Even when patients receive psychotropic medications appropriately, they may have problems that arise before their next oncology visit or before they see the person who prescribed their psychiatric medications. Psychologists, nurses and social workers play an essential role in identifying psychological and physical symptoms as well as both beneficial and problematic medication effects as they provide frontline psychosocial interventions and support for cancer patients.
This course is designed for the non-prescribing psycho-oncology clinician as well as the psychiatrist who is new to the world of Psycho-pharmaco-oncology. Oncologists, palliative care clinicians, advanced practice nurses and oncology nurses will find this course useful as well. The course will focus on key target disorders and symptoms amenable to psychopharmacological intervention, including anxiety, depression, delirium, sleep disturbance, pain, fatigue, and weight and appetite loss. Participants will learn to identify psychological reactions to medical conditions or treatments; psychiatric presentations of medical conditions or treatments; medical presentations of psychiatric conditions and common medical complications of psychiatric conditions or treatments.
Basic information will be presented about medications used to alleviate Quality of Life symptoms that arise in the cancer setting from diagnosis to survivorship or end of life care, and the interface of psychotherapy and medication management. We will review why certain medications are used and why some are avoided, looking at potential benefits, unwanted side effects, and drug-drug interactions, since you may be the first person to identify a serious adverse event. The course will also enhance your ability to provide psychoeducation to patients regarding psychiatric medications.
Live Simulcast Available:
We are pleased to offer a live simulcast for this course, available to all non-MSK employees. CME credit is offered for the live simulcast and active participation is required throughout the course. We do hope you will attend in person but understand that can sometimes be a challenge, so we are happy to offer the live simulcast as an option. Registration for the simulcast is required; please select the "Live Simulcast" option during course registration. A link to view the Symposium will be emailed to you the day before the course begins.
Participants will learn basic psycho-pharmaco-oncology and how to hone essential clinical and observation skills to improve the quality of life, mental health and safety of their patients by understanding the basics of the psychophysiology of cancer.
|Contact No. :||646-227-2025
|Registration Type||Last Date||Price|
|Physicians (MD, DO, MBBS, or equivalent) Fee||21 Mar,2020||USD 250.00|
|Residents, Fellows, Advanced Practice Providers, Nurses, Psychologists, Social Workers, Counselors and Other Healthcare Providers Fee||21 Mar,2020||USD 150.00|
|Industry Professionals Fee||21 Mar,2020||USD 425.00|
|Live Simulcast Fee||21 Mar,2020||USD 450.00|